Ligand profile
CHEMBL212478
Bioactivity hit from ChEMBL on a similar protein.
Bound to: KP13_06703 — Carbepenem-hydrolyzing beta-lactamase KPC2
Identifiers
Database identifiers and provenance.
- Ligand ID
CHEMBL212478- UniProt (similar protein)
P52663- pchembl
- 7.660 (~21.9 nM)
- Target protein
- KP13_06703
Structure
2D representation rendered from SMILES.
Physicochemical properties
Computed with RDKit from SMILES.
Drug-likeness
Descriptor-based ADME screening flags from SMILES. These are not experimental toxicity results.
Estimated from TPSA and LogP only: TPSA ≤ 90 Ų and −1 ≤ LogP ≤ 5 are treated as a favorable small-molecule permeability screen.
- TPSA ≤ 90 Ų 81.5
- −1 ≤ LogP ≤ 5 -3.78
- MW ≤ 500 Da 340.3
- LogP ≤ 5 -3.78
- H-bond donors ≤ 5 0
- H-bond acceptors ≤ 10 7
- Rotatable bonds ≤ 10 2
- TPSA ≤ 140 Ų 81.5
No PAINS structural alerts detected.
Chemical representations
Canonical representations for cheminformatics workflows.
CN1CCn2cc(/C=C3/C(=O)N4C(C(=O)[O-])=CS[C@H]34)nc2C1.[Na+]CN1CCn2cc(/C=C3/C(=O)N4C(C(=O)[O-])=CS[C@H]34)nc2C1.[Na+]
InChI=1S/C14H14N4O3S.Na/c1-16-2-3-17-5-8(15-11(17)6-16)4-9-12(19)18-10(14(20)21)7-22-13(9)18;/h4-5,7,13H,2-3,6H2,1H3,(H,20,21);/q;+1/p-1/b9-4-;/t13-;/m1./s1InChI=1S/C14H14N4O3S.Na/c1-16-2-3-17-5-8(15-11(17)6-16)4-9-12(19)18-10(14(20)21)7-22-13(9)18;/h4-5,7,13H,2-3,6H2,1H3,(H,20,21);/q;+1/p-1/b9-4-;/t13-;/m1./s1
XREVOTNYKGMPMS-FPJIVHIKSA-MXREVOTNYKGMPMS-FPJIVHIKSA-M
Provenance
Annotation context from LigQ_2, the internal Target step that collects PDB, ChEMBL, and ZINC ligand evidence.
- Method
- LigQ nearest_k
- Source
- ChEMBL
- Binding sites
- PF13354
External resources
Open this ligand in third-party databases and cheminformatics tools.
- ChEMBL ChEMBL compound CHEMBL212478 →
- UniProt UniProt P52663 (homolog) →
- PubChem PubChem (by InChIKey) →
- Cheminformatics SwissADME prediction →
- Cheminformatics SwissTargetPrediction →
- Web Google Scholar (search “CHEMBL212478”) →
Other ligands for this protein
Quick navigation to other ligands bound to KP13_06703.
PDB 36
Ligands co-crystallized with this protein (structural evidence).
ChEMBL 99
Compounds with measured inhibitory activity on this target (higher pchembl = more potent).
ZINC 50
Virtual screening candidates selected by structural similarity to known actives (Tanimoto ≥ 0.5).